... drugs price to an affordable price. I agree with the thoughts expressed by some of the speakers in the interview. Mr. Sidney Taurel, CEO of pharmaceutical giant Eli Lilly, argues that they need a high profit margin to fund the research and development of new medicines and compensate for failed research. However, according to critics such as Mrs. Marcia Angell, a senior lecturer at Harvard Medical School, the pharmaceutical industry is profitable. Profits for the pharmaceutical industry remain above 18 percent while the rest of the fortune 500 companies seem to manage with 3 percent, while the rest of the economy is doing poorly. The net profits are higher than they spend on R&D. These profit margins maybe high, but Mr. Sidney Taurel thinks price control to reduce profit margin will lead to fewer new drugs in the future. Its true price control may stifle innovation, but there are other ...

See this essay or coursework document in full right now